Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000029

Options or other derivatives

  • Chief Medical Officer acquired 52,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 1 in the form Restricted stock units +11,500 11,500 D
2022-03-01 Grant or award : show line 2 in the form Stock options (right to buy) +41,000 41,000 D
Loading xslF345X03/wf-form4_164634182660786.xml…